# A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

> **NCT04536961** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Reference Treatment- BMS-986165-01
- **DRUG:** Prototype BMS-986165
- **DRUG:** Famotidine
- **OTHER:** Alcohol

## Key facts

- **NCT ID:** NCT04536961
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-10
- **Primary completion:** 2020-12-25
- **Final completion:** 2020-12-25
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04536961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04536961, "A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04536961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*